TB 500 5mg/BPC 157 5mg
- Brand: Dragon Pharma
- Product Code: TB 500 5mg/BPC 157 5mg
- Availability: In Stock
-
$90.00
Manufacturer: Dragon Pharma
Pharmaceutical name: Thymosin Beta 4, Pentadecapeptide
Pack: 1 vial (5 mg+5 mg)
TB 500 5mg/BPC 157 5mg is a composite of peptides consisting of:
TB 500 - 5mg
BPC 157 - 5mg
TB 500 is a synthetic form of the peptide Thymosin Beta 4 (TB 500), which occurs naturally in nearly all human and animal cells. It is a leading candidate for drug development that facilitates: differentiation of endothelial cells; angiogenesis (the formation of new blood vessels from existing ones) in dermal tissues; migration of keratinocytes; deposition of collagen; and reduction of inflammation.
One of the primary ways TB 500 exerts its effects is by controlling the cell-structuring protein, Actin, which is crucial for cell integrity and movement. Actin can constitute up to 10% of all cellular proteins, highlighting its significant role in the cell's genetic profile.
This powerful peptide belongs to a well-known family of 16 closely related molecules that are highly conserved in sequence and presence across most tissues and circulating cells. TB 500 not only attaches to actin but also inhibits actin polymerization, acting as the actin-sequestering agent in eukaryotic cells.
TB 500 was recognized as a gene that experienced a four-to-six fold increase during the early stages of blood vessel formation and has been shown to aid in the development of new blood cells from pre-existing vessels. Found in wound fluid, when administered subcutaneously, it supports wound healing, muscle growth, and accelerates the recovery of muscle fibers and their cells.
BPC 157 5mg is a short peptide composed of 15 amino acids, which are the fundamental components of proteins. This peptide originates from a segment of a body protection compound (BPC) that is naturally synthesized by stomach cells. The realization that this peptide exhibits strong organ-protective and direct cell-protective properties led to its further development. Subsequent research indicated that BPC 157 can heal various tissues, including skin, muscle, tendon, ligament, and bone, in animal models. Additionally, studies show that the effects of BPC 157 are durable due to the stability of this pentadecapeptide. BPC 157 enhances the efficacy of human growth hormone by increasing the accessibility of its receptor. Therefore, combining BPC 157 with other peptides that boost the availability of human growth hormone amplifies these effects.
The reported half-life of BPC 157 is approximately 4 hours, allowing for daily dosing. Both oral and subcutaneous administration of BPC 157 are beneficial since this peptide remains stable throughout the digestive system. However, for those seeking to repair muscle and tendon, local subcutaneous or intramuscular injection is recommended for optimal outcomes.